Tango Bypasses IPO Route With SPAC Merger

Cancer Firm Will Raise $353m, List On US Stock Market In Q3

 
• By Mandy Jackson
  
SPAC vs IPO blocks
Tango did not consider a SPAC merger until its investor Boxer Capital suggested a deal • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business